Act+ Acre Cold Processed 3% Stem Cell Peptide Treatment | Boosts Hair Density | Grape Stem Cells, Peptides + Caffeine | Vegan, Fragrance-Free | 3 Fl Oz

Combat visible hair loss and thinning with the Act+Acre Cold Processed 3% Stem Cell Peptide Treatment—an advanced, clinically backed leave-in formula designed to optimize scalp health and improve hair density in just 12 weeks.* This intensive daily treatment is formulated with 3% Stem Cell Peptides to target advanced thinning and hair shedding. At the core is our proprietary complex of Grape Stem Cells, growth peptides, and antioxidants—which work together to support follicle health and create the ideal environment for thicker, fuller-looking hair. + Grape Stem Cells help protect against follicle damage and support healthy growth cycles. + Growth Peptides improve scalp elasticity and resilience, creating the optimal conditions for hair to thrive. + Caffeine invigorates the scalp and fortifies hair at the root—supporting stronger, more resilient strands. In a 12-week clinical study**: + 93% noticed less hair shedding + 93% saw a visible reduction in fallout + 86% reported new hair growth Apply daily to a clean, damp scalp. Spray 1–2 pumps per section, gently massage in, and leave on—no rinse required. The formula absorbs quickly and layers seamlessly into your routine. Vegan, fragrance-free, and color-safe, this treatment is made without sulfates, parabens, or synthetic fragrance. It’s crafted using our patented Cold Processed method to preserve ingredient potency and support long-term scalp balance. If you’re experiencing advanced hair thinning or loss, this targeted treatment delivers visible results—right from the root. *Based on results from a 12-week third-party clinical study of 90 women aged 18-65, daily use of the product was shown to support hair regrowth following acute telogen effluvium **Based on consumer perception results from a 12-week third-party clinical study of 90 women aged 18-65, daily use of the product was shown to support hair regrowth following acute telogen effluvium